We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $151M
1-Year Est. Return 76.14%
This Fund
S&P 500
This Quarter Est. Return
+13.41%
1 Year Est. Return
+76.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.4M
AUM Growth
-$9.65M
Cap. Flow
-$3.04M
Cap. Flow %
-3.56%
Top 10 Hldgs %
70.64%
Holding
94
New
32
Increased
6
Reduced
12
Closed
38

Top Buys

Rank Stock Value
1
AEON icon
AEON Biopharma
AEON
+$7.3M
2
OKYO
OKYO Pharma
OKYO
+$2.38M
3
FEMY icon
Femasys
FEMY
+$2.12M
4
TLSA icon
Tiziana Life Sciences
TLSA
+$1.7M
5
COYA icon
Coya Therapeutics
COYA
+$1.06M

Top Sells

Rank Stock Value
1
NAK
Northern Dynasty Minerals
NAK
+$831K
2
NVAX icon
Novavax
NVAX
+$698K
3
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$697K
4
DHT icon
DHT Holdings
DHT
+$654K
5
PM icon
Philip Morris
PM
+$586K

Sector Composition

Rank Sector Weight
1 Healthcare 15.6%
2 Materials 5.88%
3 Consumer Staples 2.93%
4 Financials 1.75%
5 Energy 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGD
26
DELISTED
New Gold Inc
NGD
$596K 0.7%
160,696
– –
AEON icon
27
AEON Biopharma
AEON
$13.8M
$594K 0.7%
+1,025,000
New +$7.3M
TITN icon
28
Titan Machinery
TITN
$448M
$540K 0.63%
31,678
-20,565
-39% -$340K
VALE icon
29
Vale
VALE
$62.6B
$536K 0.63%
53,677
-42,165
-44% -$398K
MUFG icon
30
Mitsubishi UFJ Financial
MUFG
$254B
$533K 0.62%
39,138
– –
INMB icon
31
CALL
INmune Bio
INMB
$50.8M
$531K 0.62%
+68,000
New +$540K
MYO icon
32
Myomo
MYO
$50.6M
$522K 0.61%
108,435
-57,761
-35% -$329K
ATYR
33
aTyr Pharma
ATYR
$49.2M
$515K 0.6%
+170,689
New +$622K
AEM icon
34
Agnico Eagle Mines
AEM
$85B
$482K 0.56%
4,450
– –
COUR icon
35
Coursera
COUR
$1.59B
$445K 0.52%
+66,750
New +$530K
PPLT
36
abrdn Physical Platinum Shares ETF
PPLT
$1.99B
$422K 0.49%
46,160
– –
COLO
37
Global X MSCI Colombia ETF
COLO
$208M
$354K 0.41%
+12,890
New +$336K
XP icon
38
XP
XP
$8.62B
$333K 0.39%
+24,226
New +$334K
FUTU icon
39
Futu Holdings
FUTU
$14.7B
$313K 0.37%
+3,061
New +$313K
CRDF icon
40
Cardiff Oncology
CRDF
$74.7M
$302K 0.35%
+96,208
New +$380K
IBRX icon
41
ImmunityBio
IBRX
$7.76B
$283K 0.33%
+94,141
New +$285K
AQST icon
42
Aquestive Therapeutics
AQST
$492M
$265K 0.31%
+91,540
New +$277K
TUR icon
43
iShares MSCI Turkey ETF
TUR
$213M
$249K 0.29%
+7,575
New +$268K
GANX icon
44
Gain Therapeutics
GANX
$75.9M
$240K 0.28%
+125,584
New +$279K
ECH icon
45
iShares MSCI Chile ETF
ECH
$1.06B
$232K 0.27%
+7,768
New +$219K
PCVX icon
46
Vaxcyte
PCVX
$8.5B
$220K 0.26%
+5,825
New +$466K
MT icon
47
ArcelorMittal
MT
$55.2B
$204K 0.24%
7,071
-21,235
-75% -$586K
WRN
48
Western Copper and Gold
WRN
$526M
$196K 0.23%
172,832
-127,660
-42% -$137K
STOK icon
49
Stoke Therapeutics
STOK
$2.06B
$190K 0.22%
+28,600
New +$267K
NVNO
50
enVVeno Medical
NVNO
$6.78M
$186K 0.22%
+2,024
New +$226K
1
2
3 4

Similar funds

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BA
Brightwater Advisory Tampa, Florida $151M AUM 17.08% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
MCCM
Morgan Creek Capital Management Chapel Hill, North Carolina $151M AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
FA
FSA Advisors Troy, Michigan $152M AUM 16.73% 1-Year Est. Return

Dauntless Investment Group's Q1 2025 Portfolio in Review

As of Q1 2025, Dauntless Investment Group held 94 positions worth $85.4M, down 10% from $95.1M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Dauntless Investment Group withdrew a net $3.04M in Q1 2025, closing 38 positions and reducing 12 holdings. Its most notable exit was Novavax, an estimated $698K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 6% a quarter earlier, followed by Materials and Consumer Staples.

Against the trend, Dauntless Investment Group opened a new position in AEON Biopharma worth $594K.

  • Dauntless Investment Group's largest Q1 2025 buy was AEON Biopharma: 1,025,000 shares worth $594K.
  • Dauntless Investment Group added most to Valaris in Q1 2025, an estimated $368K increase.
  • Dauntless Investment Group's biggest Q1 2025 reduction was Northern Dynasty Minerals, cutting an estimated $831K.
  • Dauntless Investment Group fully exited Novavax in Q1 2025, selling an estimated $698K.
  • Dauntless Investment Group's ten largest holdings make up 71% of its $85.4M portfolio in Q1 2025.
  • Dauntless Investment Group opened 32 new positions and closed 38 in Q1 2025.
  • Dauntless Investment Group's portfolio value fell 10% quarter-over-quarter to $85.4M.

Based on Dauntless Investment Group's 13F filing for Q1 2025, filed 7 May 2025.